Skip to main content
. 2016 Nov 28;18(12):1237–1242. doi: 10.1007/s12094-016-1583-0

Table 3.

Prophylactic antiemetic treatment with moderate emetogenic potential

Day 1 Day 2 Day 3
5HT-3 receptor antagonista
Dexamethasone 12 mg PO/IV Dexamethasone 8 mg PO daily Dexamethasone 8 mg PO daily

See text for alternative schemes

aPalonosetron is advised because of its superiority